Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting (Q44196778)
Jump to navigation
Jump to search
scientific article published on 10 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting |
scientific article published on 10 January 2011 |
Statements
1 reference
Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting (English)
1 reference
Richard M Bergenstal
1 reference
William H Herman
1 reference
Louis P Garrison
1 reference
Matthew Wintle
1 reference
Amy Blickensderfer
1 reference
Rolin Wade
1 reference
Likun Hou
1 reference
Lesley-Ann Miller
1 reference
Jamie Scism-Bacon
1 reference
Anthony Zagar
1 reference
Derek Misurski
1 reference
10 January 2011
1 reference
1 reference
27
1 reference
3
1 reference
531-540
1 reference
Identifiers
1 reference
1 reference